Subscribe To
Arvinas announces upcoming bavdegalutamide poster presentation at esmo congress 2023
NEW HAVEN, Conn., Oct. 15, 2023 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drug...
October 15, 2023, 10:07 pm
Oddity tech: transforming the beauty industry through data-driven growth
Oddity Tech is disrupting the beauty and wellness market through its data-driven direct-to-consumer business model. The company heavily invests in tec...
October 15, 2023, 9:12 pm
Cogent biosciences presents preclinical data highlighting precision oncology pipeline at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics
– Novel selective and reversible FGFR2 inhibitor exhibits strong potency across key primary and resistance driver mutations with potential advantage...
October 14, 2023, 4:30 pm
Longeveron announces closing of $4 million registered direct offering priced at-the-market under nasdaq rules
MIAMI, Oct. 13, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company d...
October 13, 2023, 8:05 pm
Why shares of revolution medicines were popping on friday
Revolution Medicines is a clinical-stage biotech. The company has nearly a million in cash to develop its deep pipeline....
October 13, 2023, 2:54 pm
Syndax: biotech to watch with regulatory filings before end of 2023
Syndax Pharmaceuticals, Inc. reported positive results from its phase 1/2 trial using revumenib to treat relapsed/refractory leukemia patients. The tr...
October 13, 2023, 2:52 pm
Novavax (nvax) stock slides despite vaccine availability
Despite seemingly good news, shares of biotechnology firm Novavax (NASDAQ: NVAX ) suffered a significant decline. Earlier Friday morning, management a...
October 13, 2023, 1:38 pm
Cassava shares plummet after investigation accuses researcher of ‘egregious misconduct'
Shares of biotech company Cassava Sciences Inc. were slammed in extended trading Thursday, after the pu...
October 13, 2023, 8:39 am
Top trending biotech stocks: anvs, mtnb, avtx, tpst
biotech stocks are some of the most volatile in the market because of the regular FDA updates and merge...
October 12, 2023, 11:26 am
Virios therapeutics to present at the thinkequity conference on thursday, october 19, 2023
ATLANTA, Oct. 12, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company fo...
October 12, 2023, 11:05 am
Merakris announces nationwide at-your-door autologous serum tears program
Extends Reach of Therapy for Dry Eye and Other Ocular Surface Disease Symptoms RESEARCH TRIANGLE PARK, N.C., Oct. 12, 2023 (GLOBE NEWSWIRE) — Biotec...
October 12, 2023, 10:30 am
Windtree to present at the thinkequity conference on october 19th in new york city
WARRINGTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology...
October 12, 2023, 7:30 am
Australia's csl tanks as novo nordisk's kidney trial success stokes competition concerns
Shares of biotechnology firm CSL fell to a four-year low on Thursday, after rival Novo Nordisk's Ozempic drug showed early signs of success in delayin...
October 12, 2023, 1:54 am
Gri bio (nasdaq: gri) to participate in the virtual investor ask the ceo conference
– Live moderated webcast with Marc Hertz, Chief Executive Officer of GRI Bio on Tuesday, October 24th at 11:00 AM ET LA JOLLA, CA, Oct. 11, 2023 (GL...
October 11, 2023, 1:05 pm
Nautilus biotechnology to announce third quarter financial results on october 31, 2023
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule pro...
October 11, 2023, 12:05 pm
Vir biotechnology announces multiple abstracts highlighting new chronic hepatitis b and hepatitis delta data accepted for presentation at aasld’s the liver meeting® 2023
SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that eight abstracts highlighting new data fro...
October 11, 2023, 12:00 pm
Anaptys to present phase 1 data on anb032, its btla agonist antibody, at the 32nd eadv congress
SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...
October 11, 2023, 9:15 am
Relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023
Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body weight gain in a mice model ...
October 11, 2023, 8:31 am
Nautilus biotechnology to announce third quarter financial results on october 31, 2023
SEATTLE, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule prot...
October 11, 2023, 8:05 am
Should you invest in the vaneck biotech etf (bbh)?
The VanEck biotech ETF (BBH) was launched on 12/20/2011, and is a passively managed exchange traded fun...
October 11, 2023, 7:32 am